Codexis (CDXS) Depreciation and Depletion (2017 - 2026)
Codexis (CDXS) recorded quarterly Depreciation and Depletion of $1.2 million in Q1 2026, down 5.38% quarter-over-quarter from $1.3 million in Q4 2025, and up 7.77% on a YoY basis from $1.2 million in Q1 2025.
Codexis (CDXS) Depreciation and Depletion (2017 - 2026) Analysis & Trends
Codexis' Depreciation and Depletion history runs 10 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- In Q1 2026, Depreciation and Depletion rose 7.77% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $5.2 million (up 9.18% YoY), while the FY2025 annual figure was $5.1 million, up 5.2% from the prior year.
- Depreciation and Depletion was $1.2 million for Q1 2026 at Codexis, down from $1.3 million in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $1.5 million in Q2 2023 to a low of $1.2 million in Q1 2025.
- Historically, Depreciation and Depletion has averaged $1.3 million across 5 years, with a median of $1.3 million in 2025.
- The sharpest annual moves came in 2022 and 2024: Depreciation and Depletion soared 87.29% in 2022, then slipped 16.28% in 2024.
- A 5-year view of Depreciation and Depletion shows it stood at $1.4 million in 2022, then declined by 15.61% to $1.2 million in 2023, then decreased by 3.78% to $1.2 million in 2024, then rose by 12.74% to $1.3 million in 2025, then fell by 5.38% to $1.2 million in 2026.
- The last three Depreciation and Depletion figures came in at $1.2 million (Q1 2026), $1.3 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn | 1.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.25 Mn |
| Mar 31, 2026 | 1.25 Mn |
| Dec 31, 2025 | 1.32 Mn |
| Dec 31, 2025 | 1.32 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Sep 30, 2025 | 1.32 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Mar 31, 2025 | 1.16 Mn |
| Mar 31, 2025 | 1.16 Mn |
| Dec 31, 2024 | 1.17 Mn |
| Dec 31, 2024 | 1.17 Mn |
| Sep 30, 2024 | 1.18 Mn |
| Sep 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | 1.24 Mn |
| Mar 31, 2024 | 1.25 Mn |
| Mar 31, 2024 | 1.25 Mn |
| Dec 31, 2023 | 1.22 Mn |
| Dec 31, 2023 | 1.22 Mn |